RecruitingNCT07140770

Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation


Sponsor

M.D. Anderson Cancer Center

Enrollment

66 participants

Start Date

Sep 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

To understand the changes in health-related quality of life of patients and caregivers after allogeneic hematopoietic cell transplantation.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is examining how sleep quality, physical activity, and emotional wellbeing change for both patients undergoing allogeneic hematopoietic cell transplantation (a type of stem cell transplant for blood cancers) and their primary caregivers — both during hospitalization and after discharge. Researchers are also looking at whether patients and caregivers experience these changes differently from each other. Adults (18 and older) diagnosed with a blood cancer who are scheduled for an allogeneic stem cell transplant, along with their identified primary caregiver, can participate if both have smartphone or tablet access and are able to read and consent in English. Participation involves wearing a Fitbit device to track sleep and activity, and completing online questionnaires at two timepoints during and after the transplant process. This summary was prepared with AI assistance to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFitbit

You will wear the tracker on your wrist like a watch and it will continuously (non-stop) monitor your activity, sleep, and heart rate. Functional testing will be completed with a research team member and will consist of 2 tests: testing your grip strength by having you squeeze a measuring device 3 times with your dominant hand and measuring how many minutes it takes for you to walk 15 feet.

OTHERQuestionnaire

Complete questionnaires at 3 timepoints, at the time of enrollment on the day of allogeneic hematopoietic cell transplantation, 8 days after allogeneic hematopoietic cell transplantation, and 7 days after hospital discharge.


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07140770


Related Trials